18β-glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 241-247

  Long, Danyelle R ^a   Mead, Julia ^a   Hendricks, Jay M ^a   Hardy, Michele E ^a   Voyich, Jovanka M ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBENOXOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SKIN AND SOFT TISSUE INFECTION; SKIN DEFECT; SKIN INFECTION; SOFT TISSUE INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GLYCYRRHETINIC ACID; HEMOLYSIN PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICROBIAL SENSITIVITY TESTS; SKIN; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; VIRULENCE;

EID: 84872025391     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01023-12     Document Type: Article

References (44)

1. Deleo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568.
2. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
3. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
4. Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann MC. 2007. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg. Infect. Dis. 13:1195-1200.
5. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571.
6. Stapleton PD, Taylor PW. 2002. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci. Prog. 85:57-72.
7. Asl MN, Hosseinzadeh H. 2008. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother. Res. 22:709-724.
8. Hattori T, Ikematsu S, Koito A, Matsushita S, Maeda Y, Hada M, Fujimaki M, Takatsuki K. 1989. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res. 11:255-261.
9. Kao TC, Shyu MH, Yen GC. 2010. Glycyrrhizic acid and 18beta- glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation. J. Agric. Food Chem. 58:8623-8629.
10. Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J. 2001. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab. Rev. 33:125-147.
11. Ito M, Sato A, Hirabayashi K, Tanabe F, Shigeta S, Baba M, De CE, Nakashima H, Yamamoto N. 1988. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res. 10:289-298.
12. van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW. 1998. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment. Pharmacol. Ther. 12:199-205.
13. Akamatsu H, Komura J, Asada Y, Niwa Y. 1991. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med. 57:119-121.
14. Cohen JI. 2005. Licking latency with licorice. J. Clin. Invest. 115:591-593.
15. Fiore C, Salvi M, Palermo M, Sinigaglia G, Armanini D, Toninello A. 2004. On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. Biochim. Biophys. Acta 1658:195-201.
16. Horigome H, Homma M, Hirano T, Oka K. 2001. Glycyrrhetinic acid induced apoptosis in murine splenocytes. Biol. Pharm. Bull. 24:54-58.
17. Hatano T, Kusuda M, Inada K, Ogawa TO, Shiota S, Tsuchiya T, Yoshida T. 2005. Effects of tannins and related polyphenols on methicillin-resistant Staphylococcus aureus. Phytochemistry 66:2047-2055.
18. Lee JW, Ji YJ, Yu MH, Bo MH, Seo HJ, Lee SP, Lee IS. 2009. Antimicrobial effect and resistant regulation of Glycyrrhiza uralensis on methicillin- resistant Staphylococcus aureus. Nat. Prod. Res. 23:101-111.
19. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl 1):5-16.
20. Nygaard TK, Deleo FR, Voyich JM. 2008. Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors. Curr. Opin. Infect. Dis. 21:147-152.
21. Nygaard TK, Pallister KB, Ruzevich P, Griffith S, Vuong C, Voyich JM. 2010. SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis. J. Infect. Dis. 201:241-254.
22. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, Musser JM, Deleo FR. 2005. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175:3907-3919.
23. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. 2002. Antimicrobial activity of licorice flavonoids against methicillin-resistant Staphylococcus aureus. Fitoterapia 73:536-539.
24. Hatano T, Shintani Y, Aga Y, Shiota S, Tsuchiya T, Yoshida T. 2000. Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus. Chem. Pharm. Bull. (Tokyo) 48:1286-1292.
25. Nitalikar MM, Munde KC, Dhore BV, Shikalgar SN. Studies of antibacterial activities of Glycyrrhiza glabra root extract. Int. J. PharmTech Res. 2:899-901.
26. Shamsa F, Ohtsuki K, Rezazadeh S. 2010. The anti-inflammatory and anti-viral effects of an ethnic medicine: glycyrrhizin. J. Med. Plants 9(Suppl 6):1-28.
27. Thiyagarajan P, Chandrasekaran CV, Deepak HB, Agarwal A. 2011. Modulation of lipopolysaccharide-induced pro-inflammatory mediators by an extract of Glycyrrhiza glabra and its phytoconstituents. Inflammopharmacology 19:235-241.
28. Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H, Labadie RP. 1997. Inhibition of human complement by betaglycyrrhetinic acid. Immunology 90:115-120.
29. Li HE, Qiu JZ, Yang ZQ, Dong J, Wang JF, Luo MJ, Pan J, Dai XH, Zhang Y, Song BL, Deng XM. 2012. Glycyrrhetinic acid protects mice from Staphylococcus aureus pneumonia. Fitoterapia 83:241-248.
30. Kennedy AD, Bubeck WJ, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, Deleo FR. 2010. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202:1050-1058.
31. Smith EJ, Visai L, Kerrigan SW, Speziale P, Foster TJ. 2011. The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect. Immun. 79:3801-3809.
32. Dryden MS. 2010. Complicated skin and soft tissue infection. J. Antimicrob. Chemother. 65(Suppl 3):iii35-iii44.
33. Moellering RC, Jr. 2010. The problem of complicated skin and skin structure infections: the need for new agents. J. Antimicrob. Chemother. 65(Suppl 4):iv3-iv8.
34. Miller LS, Cho JS. 2011. Immunity against Staphylococcus aureus cutaneous infections. Nat. Rev. Immunol. 11:505-518.
35. Otto M. 2010. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev. Dermatol. 5:183-195.
36. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP. 2000. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164:3713-3722.
37. Giraudo AT, Mansilla C, Chan A, Raspanti C, Nagel R. 2003. Studies on the expression of regulatory locus sae in Staphylococcus aureus. Curr. Microbiol. 46:246-250.
38. Montgomery CP, Boyle-Vavra S, Daum RS. 2010. Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 5:e15177. doi:10.1371/journal.pone.0015177.
39. Giraudo AT, Cheung AL, Nagel R. 1997. The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level. Arch. Microbiol. 168:53-58.
40. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS. 2006. Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J. Infect. Dis. 194:1267-1275.
41. Morfeldt E, Taylor D, von Gabain A, Arvidson S. 1995. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 14:4569-4577.
42. Yarwood JM, Schlievert PM. 2003. Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112:1620-1625.
43. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. 2011. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect. Immun. 79:1927-1935.
44. Zhang L, Jacobsson K, Vasi J, Lindberg M, Frykberg L. 1998. A second IgG-binding protein in Staphylococcus aureus. Microbiology 144(Pt 4):985-991.